Navigation Links
Campbell Alliance Hires Joe Dillon, Expands Business Development Practice
Date:3/9/2009

RALEIGH, N.C., March 9 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced that Joe Dillon has joined its Business Development Practice. Mr. Dillon will work closely with the Business Development Practice to help pharmaceutical and biotech clients address business challenges and develop comprehensive strategies related to in- and out-licensing, opportunity assessment, and overall business development strategy.

Mr. Dillon has more than twenty years of experience in the pharmaceutical industry. Most recently, he was the Senior Vice President and Head of Corporate Development and Valuations at the Mattson Jack Group. In this role, Mr. Dillon was responsible for designing and developing valuation, risk assessment, and deal structuring systems, as well as improving the business development partnering process. He has also been a regular speaker at many pharmaceutical-related conferences throughout the US and Europe.

"Joe has extensive expertise in business development strategy and knowledge of commercializing products. This combination of skills, coupled with his long-standing industry experience, will be a valuable asset to our firm and to the pharmaceutical and biotech clients that depend on our services," said John Campbell, CEO of Campbell Alliance.

Prior to his role at Mattson Jack, Mr. Dillon was Principal at Dillon Technologies, an executive consulting firm based in Tampa, FL. In this role, he provided management and financial consulting services to firms in challenging situations. Providing interim executive management, he served as President and CEO of Pharmaceutical Development Center, a pharmaceutical manufacturer and development company. Mr. Dillon has also held leadership positions with Oread, Inc., a pharmaceutical manufacturer and development company, and with Hoechst Marion Roussel, a multi-billion dollar pharmaceutical company and predecessor company of Sanofi-Aventis.

Mr. Dillon graduated with a BA in Business Administration with honors from Washburn University and an MBA from Kansas State University.

About the Business Development Practice at Campbell Alliance

The Business Development Practice at Campbell Alliance helps pharmaceutical licensing executives achieve an edge over the competition. Our consultants provide experienced counsel to clients who need assistance developing BD strategies, identifying partners, prioritizing targets, evaluating opportunities, and negotiating deals.

The firm's team includes seasoned consultants and industry professionals in pharmaceutical and biotech BD who have identified, assessed, and executed numerous in-licensing deals. They have also been valuable in aiding out-licensors, helping clients improve internal processes for pharmaceutical business development, and assisting top executives in charting new strategies in corporate development.

About Campbell Alliance

Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industry. The firm's clients include most of the world's top-20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function: Brand Management, Business Development, Clinical Development, Managed Markets, Sales, and Trade and Distribution. From its locations in Raleigh, NC, Parsippany, NJ, Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, Atlanta, and London, the firm serves clients throughout North America, Europe, and Japan. For more information on Campbell Alliance, please visit http://www.campbellalliance.com.

    CONTACT:
    James Forte
    Director, Public and Media Relations
    Campbell Alliance
    919-844-7100, extension 7195
    jforte@campbellalliance.com


'/>"/>
SOURCE Campbell Alliance
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Campbell Alliance to Moderate Senior-Level Panel Discussion at Windhover Pharmaceutical Strategic Alliances Conference
2. Campbell Alliance Managed Markets Practice to Take Leadership Role at CBIs Formulary and Reimbursement Conference
3. Campbell Alliance Named Best Place to Work by Triangle Business Journal
4. Campbell Alliance Business Development Practice to Moderate Two Workshops at LES Annual Meeting in Vancouver
5. Campbell Alliance Launches New Practice Area Focused on Trade and Distribution
6. Campbell Alliance Trade and Distribution Practice to Chair CBI 3rd Annual Fee for Service and EDI Data Management Conference
7. Campbell Alliance Brand Management Practice to Discuss Managing Launch Logistics at the EyeForPharma Oncology Summit
8. Campbell Alliance Brand Management and Managed Markets Practices to Speak at CBIs Early Commercialization Conference
9. Campbell Alliance Sales Practice to Conduct Workshop at EyeForPharma SFE Europe Conference
10. Campbell Alliance Managed Markets Practice to Take a Leadership Role at the CBI Forum on Effective Product Pricing and Modeling Strategies
11. Campbell Alliance Adds Doug Linton, Former Cardinal Health Executive, to Executive Advisory Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... Three-Year Initiative Supports Next Generation of ... in Life-Changing Camp Experiences ... affect the lives of children born with rare diseases, as well ... ) is announcing a new initiative designed to positively affect the ... future of rare disease care. --> To mark the ...
(Date:2/8/2016)... BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced ... companies in the TSX Venture 50 TM . ... TSX Venture Exchange, in each of five major industry sectors ... life sciences, diversified industries and technology – based on a ... market cap growth, trading volume and analyst coverage. All data ...
(Date:2/8/2016)... February 8, 2016 ... Limited, an innovation-driven oncology company developing next generation ... toxic, today announced that chairman emeritus of Tata ... in the company as part of the first ... existing investors Navam Capital and Aarin Capital. ...
(Date:2/8/2016)... 2016  BioElectronics Corporation (OTC Pink: BIEL), the ... that it is responding to a notice of ... and Exchange Commission posted on the agency website.  ... the Board of BioElectronics Corporation and the Edward ... The Fuqua School of Business, Duke University.   ...
Breaking Biology Technology:
(Date:1/20/2016)... JOSE, Calif. , Jan. 20, 2016 /PRNewswire/ ... developer of human interface solutions, today announced sampling ... controller solution for wearables and small screen applications ... such as printers. Supporting round and rectangular shapes, ... S1423 offers excellent performance with moisture on screen, ...
(Date:1/13/2016)... January 13, 2016 ... addition of the  "India Biometrics Authentication ... Forecast (2015-2020)"  report to their ... has announced the addition of the  ... - Estimation & Forecast (2015-2020)" ...
(Date:1/8/2016)... , January 8, 2016 ... market and WorldVentures ® , a privately held leading ... an Inc. 5000 fastest-growing company announced that ... investment of $2 million in Nxt-ID to develop a ... on Nxt-ID,s Wocket ® , a unique smart wallet ...
Breaking Biology News(10 mins):